PortfoliosLab logoPortfoliosLab logo
BACHY vs. BSX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BACHY vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bank of China Ltd ADR (BACHY) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BACHY achieves a 17.86% return, which is significantly higher than BSX's -49.99% return. Over the past 10 years, BACHY has outperformed BSX with an annualized return of 13.27%, while BSX has yielded a comparatively lower 7.66% annualized return.


BACHY

1D
1.51%
1M
3.82%
YTD
17.86%
6M
15.07%
1Y
20.61%
3Y*
29.74%
5Y*
20.81%
10Y*
13.27%

BSX

1D
-0.63%
1M
-15.61%
YTD
-49.99%
6M
-51.85%
1Y
-54.23%
3Y*
-2.74%
5Y*
2.89%
10Y*
7.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BACHY vs. BSX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BACHY
Bank of China Ltd ADR
17.86%23.87%43.09%14.58%10.54%14.31%-14.46%4.65%-8.11%15.60%
BSX
Boston Scientific Corporation
-49.99%6.75%54.51%24.94%8.92%18.16%-20.50%27.96%42.56%14.61%

Correlation

The correlation between BACHY and BSX is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.02

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Apr 27, 2009

0.24

Over the past year, the correlation between BACHY and BSX has dropped to 0.02 - well below their long-term average of 0.24, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

BACHY:

$198.18B

BSX:

$71.28B

EPS

BACHY:

$19.38

BSX:

$2.38

PE Ratio

BACHY:

0.87

BSX:

20.06

PEG Ratio

BACHY:

0.72

BSX:

0.45

PS Ratio

BACHY:

0.17

BSX:

3.46

PB Ratio

BACHY:

0.07

BSX:

2.76

Total Revenue (TTM)

BACHY:

$1.22T

BSX:

$20.62B

Gross Profit (TTM)

BACHY:

$635.71B

BSX:

$14.52B

EBITDA (TTM)

BACHY:

$307.28B

BSX:

$4.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BACHY vs. BSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BACHY
BACHY Risk / Return Rank: 7171
Overall Rank
BACHY Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
BACHY Sortino Ratio Rank: 7272
Sortino Ratio Rank
BACHY Omega Ratio Rank: 6767
Omega Ratio Rank
BACHY Calmar Ratio Rank: 6767
Calmar Ratio Rank
BACHY Martin Ratio Rank: 7171
Martin Ratio Rank

BSX
BSX Risk / Return Rank: 11
Overall Rank
BSX Sharpe Ratio Rank: 00
Sharpe Ratio Rank
BSX Sortino Ratio Rank: 11
Sortino Ratio Rank
BSX Omega Ratio Rank: 11
Omega Ratio Rank
BSX Calmar Ratio Rank: 22
Calmar Ratio Rank
BSX Martin Ratio Rank: 00
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BACHY vs. BSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bank of China Ltd ADR (BACHY) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BACHYBSXDifference

Sharpe ratio

Return per unit of total volatility

1.21

-1.57

+2.78

Sortino ratio

Return per unit of downside risk

1.88

-2.40

+4.28

Omega ratio

Gain probability vs. loss probability

1.21

0.65

+0.56

Calmar ratio

Return relative to maximum drawdown

1.42

-0.98

+2.40

Martin ratio

Return relative to average drawdown

4.10

-2.25

+6.35

BACHY vs. BSX - Sharpe Ratio Comparison

The current BACHY Sharpe Ratio is 1.21, which is higher than the BSX Sharpe Ratio of -1.57. The chart below compares the historical Sharpe Ratios of BACHY and BSX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BACHYBSXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.21

-1.57

+2.78

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.07

0.11

+0.95

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.65

0.28

+0.36

Sharpe Ratio (All Time)

Calculated using the full available price history

0.41

0.19

+0.22

Drawdowns

BACHY vs. BSX - Drawdown Comparison

The maximum BACHY drawdown since its inception was -53.68%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for BACHY and BSX.


Loading charts...

Drawdown Indicators


BACHYBSXDifference

Max Drawdown

Largest peak-to-trough decline

-53.68%

-89.15%

+35.47%

Max Drawdown (1Y)

Largest decline over 1 year

-13.43%

-55.91%

+42.48%

Max Drawdown (3Y)

Largest decline over 3 years

-15.70%

-55.91%

+40.21%

Max Drawdown (5Y)

Largest decline over 5 years

-16.91%

-55.91%

+39.00%

Max Drawdown (10Y)

Largest decline over 10 years

-40.98%

-55.91%

+14.93%

Current Drawdown

Current decline from peak

0.00%

-55.91%

+55.91%

Average Drawdown

Average peak-to-trough decline

-19.89%

-38.75%

+18.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.65%

24.31%

-19.66%

Volatility

BACHY vs. BSX - Volatility Comparison

The current volatility for Bank of China Ltd ADR (BACHY) is 4.52%, while Boston Scientific Corporation (BSX) has a volatility of 16.24%. This indicates that BACHY experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BACHYBSXDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.52%

16.24%

-11.72%

Volatility (6M)

Calculated over the trailing 6-month period

12.56%

32.81%

-20.25%

Volatility (1Y)

Calculated over the trailing 1-year period

17.18%

34.64%

-17.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.61%

25.66%

-6.05%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.62%

27.29%

-6.67%

Dividends

BACHY vs. BSX - Dividend Comparison

BACHY's dividend yield for the trailing twelve months is around 2.28%, while BSX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BACHY
Bank of China Ltd ADR
2.28%8.52%6.46%8.92%9.64%8.57%7.99%5.32%5.42%4.08%11.53%7.39%
BSX
Boston Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

BACHY vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between Bank of China Ltd ADR and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00B100.00B150.00B200.00B250.00B300.00B350.00B20222023202420252026
311.94B
5.20B
(BACHY) Total Revenue
(BSX) Total Revenue
Values in USD except per share items

BACHY vs. BSX - Profitability Comparison

The chart below illustrates the profitability comparison between Bank of China Ltd ADR and Boston Scientific Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%100.0%20222023202420252026
45.9%
69.4%
Portfolio components
BACHY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bank of China Ltd ADR reported a gross profit of 143.17B and revenue of 311.94B. Therefore, the gross margin over that period was 45.9%.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.

BACHY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bank of China Ltd ADR reported an operating income of 74.31B and revenue of 311.94B, resulting in an operating margin of 23.8%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.

BACHY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bank of China Ltd ADR reported a net income of 56.29B and revenue of 311.94B, resulting in a net margin of 18.0%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.


Frequently Asked Questions


BACHY and BSX have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BSX has higher volatility (16.24%) compared to BACHY (4.52%). In terms of maximum drawdown, BACHY dropped -53.68% vs BSX's -89.15%.

BACHY currently has the higher Sharpe Ratio (1.21 vs -1.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BACHY and BSX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer